THE ROSALIND FRANKLIN INSTITUTE
THE ROSALIND FRANKLIN INSTITUTE is a pri/lbg/nsc (private, limited by guarantee, no share capital, use of 'limited' exemption) registered in the United Kingdom, under 11266143, incorporated on 20 March 2018. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 8 years. Registered office address: OX11 0QX Didcot, the United Kingdom. Directors include DR GILLIAN MUNRO BURGESS, MISS CAROLINE JANE CARTER, and PROF IAN GEORGE CHARLES, and 9 others. Associated with 10 related entities, including CELL THERAPY CATAPULT LIMITED, FUTURE CARE CAPITAL, and 06299849. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
ROSALIND FRANKLIN INSTITUTE BUILDING R113 RUTHERFORD APPLETON LABORATORY
HARWELL CAMPUS
OXFORDSHIRE
OX11 0QX DIDCOT
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 11266143 | 2026-06-01 | open_in_new |